MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/0269881120936486

Медицинская библиотека · Journal of psychopharmacology (Oxford, England) · 2020

Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca.

Galvão-Coelho Nicole Leite, de Menezes Galvão Ana Cecília, de Almeida Raíssa Nóbrega, Palhano-Fontes Fernanda, Campos Braga Isaac, Lobão Soares Bruno, Maia-de-Oliveira João Paulo, Perkins Daniel, Sarris Jerome, de Araujo Draulio Barros

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Ayahuasca is a traditional Amazon brew and its potential antidepressant properties have recently been explored in scientific settings. We conducted a double-blind placebo-controlled trial of ayahuasca with treatment-resistant depression patients (n = 28) and healthy controls (n = 45).

AIMS: We are evaluating the blood inflammatory biomarkers: C-reactive protein and interleukin 6, as a potential consequence of ayahuasca intake and their correlation with serum cortisol and brain-derived neurotrophic factor levels. Blood samples were collected at pre-treatment and 48 hours after substance ingestion to assess the concentration of inflammatory biomarkers, together with administration of the Montgomery-Åsberg Depression Rating Scale.

RESULTS

At pre-treatment, patients showed higher C-reactive protein levels than healthy controls and a significant negative correlation between C-reactive protein and serum cortisol levels was revealed (rho = -0.40, n = 14). C-reactive protein in those patients was not correlated with Montgomery-Åsberg Depression Rating Scale scores. We observed a significant reduction of C-reactive protein levels across time in both patients and controls treated with ayahuasca, but not with placebo. Patients treated with ayahuasca showed a significant correlation (rho = + 0.57) between larger reductions of C-reactive protein and lower depressive symptoms at 48 hours after substance ingestion (Montgomery-Åsberg Depression Rating Scale). No significant result with respect to interleukin 6 and brain-derived neurotrophic factor was found. Furthermore, these biomarkers did not predict the antidepressant response or remission rates observed.

CONCLUSIONS

These findings enhance the understanding of the biological mechanisms behind the observed antidepressant effects of ayahuasca and encourage further clinical trials in adults with depression.

Для цитирования: Galvão-Coelho Nicole Leite, de Menezes Galvão Ana Cecília, de Almeida Raíssa Nóbrega, Palhano-Fontes Fernanda, Campos Braga Isaac, Lobão Soares Bruno, Maia-de-Oliveira João Paulo, Perkins Daniel, Sarris Jerome, de Araujo Draulio Barros. Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca.. Journal of psychopharmacology (Oxford, England). 2020. DOI: 10.1177/0269881120936486.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.